Outline

Design end-to-end wet-lab workflows including DNA/RNA extraction, library preparation, and quality control for whole-genome and targeted sequencing • Troubleshoot common protocol failures such as adapter dimer formation, PCR amplification bias, and sample cross-contamination using gel electrophoresis and qPCR validation • Execute standardized sample tracking, batch recording, and chain-of-custody documentation to ensure reproducible multi-center sequencing studies

Outline

Construct automated variant calling pipelines using BWA-MEM for alignment, GATK HaplotypeCaller for SNP/indel detection, and ANNOVAR for functional annotation • Develop reproducible analysis environments by containerizing workflows with Docker/Singularity and orchestrating pipelines with Snakemake or Nextflow • Visualize genomic data tracks, coverage profiles, and structural variants using Integrative Genomics Viewer (IGV) and UCSC Genome Browser for manual curation

Outline

Calculate statistical power and sample sizes for case-control, cohort, and family-based sequencing studies using tools like GATK-SV or power calculators • Design balanced experimental layouts with proper randomization, blocking, and batch effect controls to minimize confounding in multi-lane sequencing runs • Formulate falsifiable hypotheses and define primary/secondary endpoints aligned with FAIR data principles for publishable NGS research

Outline

Integrate multi-omics datasets by combining RNA-seq expression quantification with ChIP-seq peak calling and ATAC-seq chromatin accessibility analysis • Apply machine learning classifiers such as random forests and deep neural networks to predict disease phenotypes from variant burden scores and pathway enrichment data • Interpret clonal evolution trajectories and tumor mutational burden from single-cell and bulk whole-exome sequencing in precision oncology contexts

Outline

Navigate CLIA/CAP accreditation requirements, FDA guidance on NGS-based diagnostics, and GDPR/HIPAA frameworks for genomic data privacy • Evaluate informed consent protocols for secondary use of genomic data, return of incidental findings, and data sharing through controlled-access repositories like dbGaP • Implement cybersecurity measures including encryption, access logging, and de-identification pipelines to protect sensitive human genomic datasets

Outline

Assess commercial NGS service models, diagnostic assay development timelines, and regulatory submission strategies from Illumina, Thermo Fisher, and emerging biotech case studies • Analyze cost-per-sample economics, turnaround time optimization, and CLIA-lab operational workflows for clinical and pharmaceutical NGS deployment • Construct professional portfolios demonstrating end-to-end project ownership, cross-functional collaboration, and stakeholder communication for biotech hiring managers